| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 306.15B | 311.55B | 307.70B | 329.39B | 284.10B | 216.23B |
| Gross Profit | 40.72B | 40.52B | 38.73B | 37.06B | 30.65B | 26.36B |
| EBITDA | 15.62B | 16.46B | 16.13B | 13.87B | 10.56B | 4.47B |
| Net Income | 10.01B | 11.66B | 9.62B | 8.12B | 6.81B | 1.25B |
Balance Sheet | ||||||
| Total Assets | 139.95B | 146.08B | 143.35B | 143.20B | 134.12B | 110.59B |
| Cash, Cash Equivalents and Short-Term Investments | 21.77B | 23.81B | 21.46B | 18.96B | 12.24B | 17.83B |
| Total Debt | 1.58B | 1.66B | 3.15B | 5.43B | 5.50B | 2.52B |
| Total Liabilities | 48.39B | 53.97B | 61.25B | 71.04B | 69.02B | 51.76B |
| Stockholders Equity | 91.48B | 92.01B | 82.06B | 72.16B | 65.06B | 58.80B |
Cash Flow | ||||||
| Free Cash Flow | 926.50M | 6.40B | 9.45B | 9.51B | -2.41B | 4.80B |
| Operating Cash Flow | 1.03B | 7.14B | 9.69B | 9.60B | -2.33B | 5.89B |
| Investing Cash Flow | 93.50M | -1.03B | -2.71B | -261.00M | 197.00M | -357.00M |
| Financing Cash Flow | -1.07B | -4.78B | -5.38B | -3.10B | -4.01B | -887.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥344.98B | 7.92 | 11.34% | 3.38% | 3.44% | 6.97% | |
75 Outperform | ¥151.95B | 9.78 | ― | 2.66% | -1.63% | 67.13% | |
73 Outperform | ¥111.36B | 10.14 | ― | 3.74% | -2.33% | -16.42% | |
73 Outperform | ¥395.68B | 9.25 | ― | 3.13% | 1.50% | 9.82% | |
65 Neutral | ¥259.94B | 14.72 | 8.35% | 2.73% | 3.35% | 810.44% | |
65 Neutral | ¥1.26T | 7.20 | 11.17% | 3.24% | 2.12% | 18.93% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |